New
Image
04.02.2025
Our response to serious supply issues of drugs for people with type 2 ...
The NHS had been facing supply issues with glucagon-like peptide receptor agonists (GLP-1 RAs, or GLP-1 a...
In our January research highlights, we look at new research into how AI-powered screening could spot type 2 diabetes risk years in advance, and a new study into genetically altered beta cell therapy tested in type 1 diabetes.
Read more